Wheatley Joshua L, Holyoak Todd
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6626-31. doi: 10.1073/pnas.0701983104. Epub 2007 Apr 10.
The high-resolution crystal structure of kexin (Kex2) in complex with a peptidyl-chloromethylketone inhibitor containing a noncognate lysine at the P(1) position provides the structural basis for the differential lysine/arginine selectivity that defines the prohormone (proprotein) convertase (PC) family. By comparison with the previous structures of Kex2 and furin, this structure of the acylated enzyme provides a basis for the observed decrease in the acylation rate with substrates containing a lysine at P(1) and the absence of an effect on the deacylation rate without involving mobility of the S(1) lid. The structure of the complex shows that a secondary subsite in the S(1) pocket is present, and that this site recognizes and binds the P(1) lysine in a more shallow fashion than arginine. This results in a displacement of the bound peptide away from the S385 nucleophile relative to substrates containing a P(1) arginine. It is concluded that this alternate binding site and resultant displacement of the scissile bond in the active site results in the observed decrease in the acylation rate. Studies of the inactivation kinetics of Kex2 by two peptidyl chloromethylketone inhibitors demonstrates that the selectivity between lysine and arginine at the P(1) position arises at the acylation step, consistent with what was observed with peptidyl substrates [Rockwell NC, Fuller RS (2001) J Biol Chem 276:38394-38399].
与在P(1)位置含有非同源赖氨酸的肽基氯甲基酮抑制剂形成复合物的克新(Kex2)的高分辨率晶体结构,为定义激素原(前体蛋白)转化酶(PC)家族的赖氨酸/精氨酸差异选择性提供了结构基础。通过与Kex2和弗林蛋白酶的先前结构进行比较,这种酰化酶的结构为观察到的P(1)位置含有赖氨酸的底物酰化速率降低以及对脱酰化速率无影响(不涉及S(1)盖子的移动)提供了基础。复合物的结构表明,S(1)口袋中存在一个二级亚位点,并且该位点以比精氨酸更浅的方式识别并结合P(1)赖氨酸。这导致与含有P(1)精氨酸的底物相比,结合肽相对于S385亲核试剂发生位移。得出的结论是,这个替代结合位点以及活性位点中可裂解键的由此产生的位移导致观察到的酰化速率降低。对两种肽基氯甲基酮抑制剂使Kex2失活的动力学研究表明,P(1)位置赖氨酸和精氨酸之间的选择性出现在酰化步骤,这与肽基底物的观察结果一致[罗克韦尔NC,富勒RS(2001年)《生物化学杂志》276:38394 - 38399]。